RE: Exponential growth..29 Dec 2021 18:33
Exactly @maq.
Also from the prelims :
"We strongly believe that we are at the start of a paradigm-shift in the use and application of rapid testing"
"Our long-term strategic objective is to become the largest automated manufacturer of lateral flow tests globally."
(and this little nuggett)...
"We have received significant purchase orders for manufacturing batches from Vatic and Avacta,in advance of completion of technical transfer of their products"
They've already stated Avacta TT due by end of year and a range of other TTs are in their final stages.
MCap of just £40m,fully funded and owed over £9m from the DHSC (having signed a non-binding agreement and recently had very encouraging discussions for it's collection).Flexible production to move with any new variants,distribution agreements signed,expansion complete,..about to pop ?